Baruch-Suchodolsky Rozena, Fischer Bilha
Department of Chemistry, Gonda-Goldschmied Medical Research Center, Bar-Ilan University, Ramat-Gan 52900, Israel.
Biochemistry. 2009 May 26;48(20):4354-70. doi: 10.1021/bi802361k.
The brains of individuals diagnosed with Alzheimer's disease (AD) are characterized by amyloid plaques, of which the major component is Abeta peptide. Excessive Cu and Fe ions binding to Abeta were suggested to have a deleterious effect on promoting both the aggregation of Abeta and the generation of reactive oxygen species (ROS). Other studies suggested that Abeta plays a protective role by acting as an antioxidant at nanomolar concentrations. The apparent confusion regarding the antioxidant and pro-oxidant properties of Abeta(40) encouraged us to explore the modulatory role of Abeta(40) at the molecular level under oxidative stress conditions. Here, we focused on Abeta(40) in the simplest oxidative system, namely, Cu(I)/Cu(II)/Fe(II)-H(2)O(2). Using ESR, we monitored the production of OH radicals in the above-mentioned systems in the presence of Abeta(40). We found that Abeta(40), either in its soluble or in its aggregated form, functioned as a remarkably potent antioxidant in Cu(I)/Fe(II)-catalyzed radical-producing systems and slightly less potently in the presence of Cu(II) with IC(50) values of 13-62 muM. Abeta(40) proved to be 3.8-6.5 and 15-42 times more potent than the soluble Abeta(28) and the potent antioxidant Trolox, respectively, in the Cu(I)/Fe(II)-H(2)O(2) systems. Time-dependent enhancement of ROS production by Abeta(40) occurs only at low concentrations of aggregated Abeta(40) and in the presence of Cu(II). On the basis of the extremely low IC(50) values of Abeta(40) and the extensive oxidative damage caused to Abeta(40) in Cu(I)/Fe(II)-H(2)O(2) systems, we propose that radical scavenging is the major mechanism of antioxidant activity of Abeta(40) in addition to metal ion chelation. In summary, Abeta(40), either soluble or aggregated, at either nanomolar or micromolar concentrations is a highly potent antioxidant in cell-free oxidative systems, acting mainly as a radical scavenger. Therefore, we propose that it is not the Abeta(40)-Cu(I)/Fe(II) complex per se that is responsible for the oxidative damage in AD.
被诊断患有阿尔茨海默病(AD)的个体大脑具有淀粉样斑块的特征,其主要成分是β-淀粉样肽(Aβ)。有研究表明,过量的铜离子和铁离子与Aβ结合会对促进Aβ聚集和活性氧(ROS)生成产生有害影响。其他研究则表明,Aβ在纳摩尔浓度下作为抗氧化剂发挥保护作用。关于Aβ(40)抗氧化和促氧化特性的明显矛盾促使我们在氧化应激条件下从分子水平探索Aβ(40)的调节作用。在此,我们聚焦于最简单的氧化体系中的Aβ(40),即铜(I)/铜(II)/铁(II)-过氧化氢体系。我们使用电子顺磁共振(ESR)技术,在有Aβ(40)存在的情况下监测上述体系中羟基自由基的产生。我们发现,无论是可溶性还是聚集态的Aβ(40),在铜(I)/铁(II)催化的自由基生成体系中都发挥着显著有效的抗氧化剂作用,在有铜(II)存在时效力稍弱,半数抑制浓度(IC50)值为13 - 62 μM。在铜(I)/铁(II)-过氧化氢体系中,Aβ(40)的抗氧化能力分别比可溶性Aβ(28)和强效抗氧化剂生育三烯酚(Trolox)强3.8 - 6.5倍和15 - 42倍。仅在低浓度聚集态Aβ(40)且有铜(II)存在时,Aβ(40)才会随时间增强ROS生成。基于Aβ(40)极低的IC50值以及在铜(I)/铁(II)-过氧化氢体系中Aβ(40)受到的广泛氧化损伤,我们提出除了金属离子螯合作用外,自由基清除是Aβ(40)抗氧化活性的主要机制。总之,无论是可溶性还是聚集态的Aβ(40),在纳摩尔或微摩尔浓度下在无细胞氧化体系中都是高效抗氧化剂,主要作为自由基清除剂发挥作用。因此,我们认为并非Aβ(40)-铜(I)/铁(II)复合物本身导致AD中的氧化损伤。